Equities

Wellell Inc

4106:TAI

Wellell Inc

Actions
Health CareMedical Equipment and Services
  • Price (TWD)28.50
  • Today's Change0.05 / 0.18%
  • Shares traded186.10k
  • 1 Year change-24.00%
  • Beta--
Data delayed at least 20 minutes, as of Jun 28 2024.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Wellell Inc, formerly Apex Medical Corp, is a Taiwan-based company principally engaged in the manufacture, trading, import and export of medical and healthcare related equipment. The main products include the wound management (WM) series, respiratory therapy (RT) series, welfare equipment, as well as the electronic medical devices (EMD) series, such as four-wheel walk helpers, crutches, wheelchairs, shower devices, automatic positive airway pressure (APAP) devices, interferential stimulators, electrical muscle stimulators (EMSs) and liquid crystal display (LCD) massage devices. The Company mainly distributes products to Europe, the Americas and Asia.

  • Revenue in TWD (TTM)2.59bn
  • Net income in TWD141.45m
  • Incorporated1990
  • Employees535.00
  • Location
    Wellell IncNo.9Min Sheng Street, Peibei LiTucheng DistrictNEW TAIPEI 236TaiwanTWN
  • Phone+886 222685568
  • Fax+886 222689521
  • Websitehttps://www.apexmedicalcorp.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Wellell Inc2.59bn141.45m2.88bn535.0020.411.2312.221.111.401.4025.6123.100.80313.015.19--4.393.935.715.2843.2341.745.475.231.70345.950.140653.08-0.62324.68-5.727.02-28.564.24
Medimaging Integrated Solution Inc511.96m50.80m3.05bn--59.253.9034.525.961.491.4915.0122.630.4581.485.73--4.547.485.339.1455.2754.059.9212.023.27--0.362563.116.987.875.764.7912.39--
OK Biotech Co Ltd1.22bn21.02m3.72bn62.00171.431.5439.093.040.14760.14768.7416.460.39512.622.49--0.64163.060.80744.0813.3320.271.626.011.57--0.1003118.40-19.651.25-97.95-55.0972.81-31.15
Data as of Jun 28 2024. Currency figures normalised to Wellell Inc's reporting currency: Taiwan Dollar TWD

Institutional shareholders

0.72%Per cent of shares held by top holders
HolderShares% Held
Dimensional Fund Advisors LPas of 06 Jun 2024610.46k0.61%
Dimensional Fund Advisors Ltd.as of 30 Apr 202448.87k0.05%
State Board of Administration of Florida Retirement Systemas of 30 Jun 202341.00k0.04%
Acadian Asset Management LLCas of 30 Sep 202322.30k0.02%
DFA Australia Ltd.as of 30 Apr 20242.62k0.00%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.